CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells
Top Cited Papers
Open Access
- 4 June 2025
- journal article
- Published by Springer Nature in Nature
- Vol. 643 (8073) , 1076-1086
Abstract
Chimeric antigen receptor (CAR) natural killer (NK) cell immunotherapy offers a promising approach against cancer1-3. However, the molecular mechanisms that regulate CAR-NK cell activity remain unclear. Here we identify the transcription factor cyclic AMP response element modulator (CREM) as a crucial regulator of NK cell function. Transcriptomic analysis revealed a significant induction of CREM in CAR-NK cells during the peak of effector function after adoptive transfer in a tumour mouse model, and this peak coincided with signatures of both activation and dysfunction. We demonstrate that both CAR activation and interleukin-15 signalling rapidly induce CREM upregulation in NK cells. Functionally, CREM deletion enhances CAR-NK cell effector function both in vitro and in vivo and increases resistance to tumour-induced immunosuppression after rechallenge. Mechanistically, we establish that induction of CREM is mediated by the PKA-CREB signalling pathway, which can be activated by immunoreceptor tyrosine-based activation motif signalling downstream of CAR activation or by interleukin-15. Finally, our findings reveal that CREM exerts its regulatory functions through epigenetic reprogramming of CAR-NK cells. Our results provide support for CREM as a therapeutic target to enhance the antitumour efficacy of CAR-NK cells.Keywords
This publication has 77 references indexed in Scilit:
- The Cyclic AMP Response Element Modulator Regulates Transcription of the TCR ζ-ChainThe Journal of Immunology, 2005
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- TCR- and CD28-Mediated Recruitment of Phosphodiesterase 4 to Lipid Rafts Potentiates TCR SignalingThe Journal of Immunology, 2004
- Engagement of Natural Cytotoxicity Programs Regulates AP-1 Expression in the NKL Human NK Cell LineThe Journal of Immunology, 1999
- Role of Transcriptional Repressor ICER in Cyclic AMP-mediated Attenuation of Cytokine Gene Expression in Human ThymocytesJournal of Biological Chemistry, 1998
- Transcriptional control of circadian hormone synthesis via the CREM feedback loopProceedings of the National Academy of Sciences, 1996
- The key role of CREM in the cAMP signaling pathway in the testisMolecular and Cellular Endocrinology, 1994
- Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressorCell, 1993
- Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun.Journal of Biological Chemistry, 1992
- CREM gene: Use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcriptionCell, 1991